首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1340770

全球基因編輯市場預測（~2030年）

Gene editing Market Research Report Forecast to 2030

出版日期: 2023年08月23日 | 出版商:

Market Research Future | 英文 120 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預測期內，全球基因編輯市場規模預計將以 20.9% 的複合年增長率增長。

區域考慮

預計2022年北美市場規模將超過20億美元，研究期間複合年增長率為21.19%。該市場的推動因素包括惡性腫瘤等遺傳疾病的擴散、對個性化醫療的日益關注、公共和私營部門資金的增加以及測序和基因編輯創新的快速發展。

歐洲市場預計將佔據第二大市場份額。醫療保健服務 IT 領域的技術進步，例如使用計算機推理 (AI) 來生成 CRISPR 框架，正在推動市場發展。

2023年至2030年，亞太市場預計將以24.03%的複合年增長率發展。

中東在中東和非洲佔有很大的市場份額。政府支持的發展、公私組織的崛起以及補貼的擴大正在促進該地區生物技術產業的發展。

本報告對全球基因編輯市場進行研究和分析，提供市場動態、區域和細分分析、公司簡介等。

Genomic editing alludes to the procedures and methods used to alter the genetic data of any living life form. Genome editing includes the alteration of genes in numerous areas utilizing recombinant innovation, which increments addition accuracy and diminishes cell poisonousness. An assortment of innovations permits researchers to modify a creature's DNA. These advancements empower adding, erasing, or changing genetic material at explicit areas inside the genome. Ascend in the quantity of key drives as consolidations, acquisitions, item endorsement, coordinated efforts, and organizations to acquire an upper hand and proposition progressed treatment choices for genomic editing.

Market Segmentation

Technology-based segments of the gene editing market include CRISPR, TALEN, ZFN, antisense, and others.

Genetic engineering, gene therapy, cell line engineering, and other applications make up the market segments of gene editing.

Gene editing market segmentation is based on biotechnology and pharmaceutical firms, contract research organizations (CROs), university & government research institutes, and contract research organizations (CROs).

Regional Insights

The North American gene editing market is supposed to represent over USD 2 billion in 2022 and is supposed to show a 21.19% CAGR during the review time frame. This is credited to the expansion of malignant growth and other genetic problems, a developing inclination for customized medication, an expansion in private and public area financing, and quick progressions in sequencing and gene editing innovations are driving the market for gene editing in the North America region.

Europe gene editing market is supposed to represent the second-biggest market share because of mechanical headways in medical services IT like the utilization of Computerized reasoning (man-made intelligence) to fabricate CRISPR frameworks are driving development drive the market development of gene editing in Europe.

The Asia-Pacific gene editing market is supposed to develop at a CAGR of 24.03% from 2023 to 2030. This is because of the rising mechanical leap forwards, a flourishing biotechnology industry in arising regions, and the rising commonness of disease and other genetic irregularities.

The Rest of the World incorporates the Middle East, Africa, and Latin America. Middle East holds the significant market share in the Middle East and Africa region because of a few main considerations, for example, developing government support, rising public-private organizations, and expanded subsidizing are adding to the region's biotechnology industry's development.

Major Players

Key Companies in the Gene editing Market Include GE Healthcare (US), Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Lonza (Switzerland), GenScript (US), Horizon Discovery Ltd (UK), OriGene Technologies, Inc (US), Integrated DNA Technologies, Inc (US), New England Biolabs, Inc (US), and Sangamo Therapeutics (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING FUNDING FOR GENETIC RESEARCH
- 4.2.2 RISING INCIDENCE OF GENETIC DISORDERS
- 4.2.3 GROWING NUMBER OF STRATEGIC INITIATIVES
4.3 RESTRAINTS
- 4.3.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY
- 4.3.2 HIGH COST OF EQUIPMENT
4.4 OPPORTUNITIES
- 4.4.1 INCREASING APPLICATION AREAS OF GENE EDITING

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D DESIGNING
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL GENE EDITING MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON REGIONS
- 5.3.3 IMPACT ON SUPPLY GAP ANALYSIS
- 5.3.4 IMPACT ON PRICING

6 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY

6.1 OVERVIEW
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 ANTISENSE
6.6 OTHERS

7 GLOBAL GENE EDITING MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 GENETIC ENGINEERING
7.3 GENE THERAPY
7.4 CELL LINE ENGINEERING
7.5 OTHERS

8 GLOBAL GENE EDITING MARKET, BY END USER

8.1 OVERVIEW
8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

9 GLOBAL GENE EDITING MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 AUSTRALIA
- 9.4.5 SOUTH KOREA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA
- 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL GENE EDITING MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL GENE EDITING MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT EXPANSION AND LAUNCH
- 10.6.2 AGREEMENT/COLLABORATION
10.7 FINANCIAL MATRIX
- 10.7.1 SALES (USD MILLION), 2021
- 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

11.1 BIO-RAD LABORATORIES, INC
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 GE HEALTHCARE
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 GENSCRIPT
- 11.3.1 COMPANY OVERVIEWS
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 INTEGRATED DNA TECHNOLOGIES, INC
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 NEW ENGLAND BIOLABS
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 SANGAMO THERAPEUTICS
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 THERMO FISHER SCIENTIFIC, INC
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 LONZA
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 KEY STRATEGIES
11.9 HORIZON DISCOVERY LTD
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 ORIGENE TECHNOLOGIES, INC
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

簡介目錄圖表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
TABLE 3 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 36
TABLE 4 GLOBAL GENE EDITING MARKET, FOR CRISPR, BY REGION, 2019-2030 (USD MILLION) 36
TABLE 5 GLOBAL GENE EDITING MARKET, FOR TALEN, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 6 GLOBAL GENE EDITING MARKET, FOR ZFN, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 7 GLOBAL GENE EDITING MARKET, FOR ANTISENSE, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 8 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 38
TABLE 9 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 41
TABLE 10 GLOBAL GENE EDITING MARKET, FOR GENETIC ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 41
TABLE 11 GLOBAL GENE EDITING MARKET, FOR GENE THERAPY, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 12 GLOBAL GENE EDITING MARKET, FOR CELL LINE ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 13 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 14 GLOBAL GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 45
TABLE 15 GLOBAL GENE EDITING MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2019-2030 (USD MILLION) 45
TABLE 16 GLOBAL GENE EDITING MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2030 (USD MILLION) 46
TABLE 17 GLOBAL GENE EDITING MARKET, FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2030 (USD MILLION) 46
TABLE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2019-2030 (USD MILLION) 47
TABLE 19 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 50
TABLE 20 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 51
TABLE 21 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 51
TABLE 22 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 51
TABLE 23 US: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 52
TABLE 24 US: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 52
TABLE 25 US: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 52
TABLE 26 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 53
TABLE 27 CANADA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 53
TABLE 28 CANADA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 53
TABLE 29 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 55
TABLE 30 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 56
TABLE 31 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 56
TABLE 32 EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 57
TABLE 33 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 57
TABLE 34 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 58
TABLE 35 GERMANY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 58
TABLE 36 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 58
TABLE 37 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 59
TABLE 38 FRANCE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 59
TABLE 39 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 59
TABLE 40 UK: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 60
TABLE 41 UK: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 60
TABLE 42 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 60
TABLE 43 ITALY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 61
TABLE 44 ITALY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 61
TABLE 45 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 61
TABLE 46 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 62
TABLE 47 SPAIN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 62
TABLE 48 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 62
TABLE 49 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 63
TABLE 50 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 63
TABLE 51 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 65
TABLE 52 ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 65
TABLE 53 ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 66
TABLE 54 ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 66
TABLE 55 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 67
TABLE 56 CHINA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 67
TABLE 57 CHINA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 68
TABLE 58 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 68
TABLE 59 INDIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 68
TABLE 60 INDIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 69
TABLE 61 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 69
TABLE 62 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 70
TABLE 63 JAPAN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 70
TABLE 64 AUSTRALIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 71
TABLE 65 AUSTRALIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 71
TABLE 66 AUSTRALIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 71
TABLE 67 SOUTH KOREA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 72
TABLE 68 SOUTH KOREA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 72
TABLE 69 SOUTH KOREA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 72
TABLE 70 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 73
TABLE 71 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 73
TABLE 72 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 73
TABLE 73 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2019-2030 (USD MILLION) 75
TABLE 74 REST OF THE WORLD: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 75
TABLE 75 REST OF THE WORLD: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 76
TABLE 76 REST OF THE WORLD: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 76
TABLE 77 MIDDLE EAST: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 77
TABLE 78 MIDDLE EAST: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 77
TABLE 79 MIDDLE EAST: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 77
TABLE 80 AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 78
TABLE 81 AFRICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 78
TABLE 82 AFRICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 78
TABLE 83 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 79
TABLE 84 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 79
TABLE 85 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 79
TABLE 86 MAJOR PLAYERS IN THE GLOBAL GENE EDITING MARKET 80
TABLE 87 MOST ACTIVE PLAYER IN THE GLOBAL GENE EDITING MARKET 82
TABLE 88 PRODUCT EXPANSION AND LAUNCH: GLOBAL GENE EDITING MARKET 83
TABLE 89 AGREEMENT/COLLABORATION: GLOBAL GENE EDITING MARKET 84
TABLE 90 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 87
TABLE 91 GE HEALTHCARE: PRODUCTS OFFERED 90
TABLE 92 GENSCRIPT: PRODUCTS OFFERED 93
TABLE 93 GENSCRIPT: KEY DEVELOPMENTS 93
TABLE 94 INTEGRATED DNA TECHNOLOGIES, INC: PRODUCTS OFFERED 95
TABLE 95 INTEGRATED DNA TECHNOLOGIES, INC: KEY DEVELOPMENTS 96
TABLE 96 NEW ENGLAND BIOLABS: PRODUCTS OFFERED 97
TABLE 97 SANGAMO THERAPEUTICS: PRODUCTS OFFERED 100
TABLE 98 SANGAMO THERAPEUTICS: KEY DEVELOPMENTS 100
TABLE 99 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 103
TABLE 100 LONZA: PRODUCTS OFFERED 106
TABLE 101 LONZA: KEY DEVELOPMENTS 106
TABLE 102 HORIZON DISCOVERY LTD: PRODUCTS OFFERED 107
TABLE 103 HORIZON DISCOVERY LTD: KEY DEVELOPMENTS 107
TABLE 104 ORIGENE TECHNOLOGIES, INC: PRODUCTS OFFERED 109

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15
FIGURE 2 GLOBAL GENE EDITING MARKET 16
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL GENE EDITING MARKET 25
FIGURE 5 DRIVER IMPACT ANALYSIS 27
FIGURE 6 RESTRAINT IMPACT ANALYSIS 28
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL GENE EDITING MARKET 29
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL GENE EDITING MARKET 31
FIGURE 9 GLOBAL GENE EDITING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD MILLION) 35
FIGURE 10 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2022 & 2030 (USD MILLION) 35
FIGURE 11 GLOBAL GENE EDITING MARKET SHARE (%), BY TECHNOLOGY, 2022 36
FIGURE 12 GLOBAL GENE EDITING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD MILLION) 40
FIGURE 13 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 40
FIGURE 14 GLOBAL GENE EDITING MARKET SHARE (%), BY APPLICATION, 2022 41
FIGURE 15 GLOBAL GENE EDITING MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 43
FIGURE 16 GLOBAL GENE EDITING MARKET, BY END USER, 2022 & 2030 (USD MILLION) 44
FIGURE 17 GLOBAL GENE EDITING MARKET SHARE (%), BY END USER, 2022 45
FIGURE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 47
FIGURE 19 GLOBAL GENE EDITING MARKET SHARE (%), BY REGION, 2022 48
FIGURE 20 NORTH AMERICA MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 49
FIGURE 21 NORTH AMERICA: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 50
FIGURE 22 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 50
FIGURE 23 EUROPE MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 54
FIGURE 24 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 55
FIGURE 25 EUROPE: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 56
FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 64
FIGURE 27 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 64
FIGURE 28 ASIA-PACIFIC: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 65
FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 74
FIGURE 30 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 74
FIGURE 31 REST OF THE WORLD: GENE EDITING MARKET SHARE (%), BY REGION, 2022 75
FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS 81
FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL GENE EDITING MARKET 82
FIGURE 34 GLOBAL GENE EDITING MARKET: COMPETITIVE LANDSCAPE 83
FIGURE 35 SALES 2021 84
FIGURE 36 RESEARCH & DEVELOPMENT EXPENDITURE, 2021 85
FIGURE 37 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT 87
FIGURE 38 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 88
FIGURE 39 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 90
FIGURE 40 GE HEALTHCARE: SWOT ANALYSIS 91
FIGURE 41 GENSCRIPT: FINANCIAL OVERVIEW SNAPSHOT 92
FIGURE 42 GENSCRIPT: SWOT ANALYSIS 94
FIGURE 43 SANGAMO THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT 99
FIGURE 44 SANGAMO THERAPEUTICS: SWOT ANALYSIS 101
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 104
FIGURE 47 LONZA: FINANCIAL OVERVIEW SNAPSHOT 105